Ulcerative colitis (acute exacerbations) - infliximab
Infliximab for the treatment of acute exacerbations of ulcerative colitis
Summary
Infliximab is recommended as a possible treatment for people with acute, severely active ulcerative colitis only if:
- ciclosporin is considered inappropriate for them, or
- they are taking part in a research study (clinical trial)
Guidance documents
Implementing this guidance
Other information
We will consult on our review plans for this guidance in December 2011
About this guidance
Technology appraisals TA163
Issued: December 2008
How this guidance was produced